NEWS

UK drug regulator announced that it has approved the first oral antiviral for treatment of Covid-19. The drug, molnupiravir, has been developed by Merck and Ridgeback

ABOUT

• Developed initially to treat influenza
• Has been repurposed to treat Covid patients
• Interferes with the replication of SARS-CoV-2, thereby reducing severity of disease.
• Most effective when used early
• UK has recommended its use as soon as possible following a positive test and within five days of symptoms onset.